<DOC>
	<DOCNO>NCT02336607</DOCNO>
	<brief_summary>The purpose study evaluate effect blood pressure control , pulse wave velocity , well safety tolerability felodipine single combine drug Chinese Hypertension patient .</brief_summary>
	<brief_title>The Effects Blood Pressure Control , Pulse Wave Velocity , Well Safety Tolerability Felodipine Sustained Release Chinese Patients .</brief_title>
	<detailed_description>In study , investigator choose male female subject age 35 79 year old mild moderate essential hypertension . At first 2 week , patient use felodipine 5mg daily . If blood pressure dose n't meet target ( 140/90mmHg ) , randomize metoprolol , lisinopril hydrochlorothiazide combination group another 4 week therapy . After , blood pressure still meet target , up-titrate felodipine 10mg , follow 4 week therapy . And blood pressure still meet target , up-titrate combine drug maximum dosage . The whole treatment duration 14 week . The primary outcome evaluate percentage subject reach blood pressure target ( defined &lt; 140 / 90 mmHg ) 14 week treatment felodipine sustain release combination metoprolol , lisinopril hydrochlorothiazide .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>1 . Provision write informed consent 2 . Female male age 3579 year old 3 . Mild moderate essential hypertension patient meet following criterias : Newly diagnose , drugnaive , without antihypertension treatment least 3 month , moderate essential hypertension patient . ( 160mmHg mean SiSBP 180mmHg 100mmHg mean SiDBP 110mmHg ) Newly diagnose , drugnaive , without antihypertension treatment least 3 month , mild essential hypertension patient ( 140mmHg mean SiSBP 160mmHg 90mmHg mean SiDBP 100mmHg ) high extreme high cardiovascular risk ( ) ( 3 3 risk factor and/or target organ lesion and/or diabetes mellitus ) . ( ) accord Chinese guideline prevention treatment patient hypertension 2004 . The patient already receive starting dosage single antihypertension drug therapy ( exclude drug contain felodipine component ) , however blood pressure well control ( 140mmHg mean SiSBP 160mmHg 90mmHg mean SiDBP 100mmHg ) . After stop drug 5 eliminate half life time , patient meet one follow two : 1 . 160mmHg mean SiSBP 180mmHg 100mmHg mean SiDBP 110mmHg . 2 . 140mmHg mean SiSBP 160mmHg 90mmHg mean SiDBP 100mmHg ) high extreme high cardiovascular risk* ( 3 3 risk factor and/or target organ lesion and/or diabetes mellitus ) . Sitting blood pressure take subject take seat rest 5 minute next medication . Any follow regarded criterion exclusion study : 1 . Known suspected secondary hypertension 2 . Resting heart rate &lt; 55bpm . 3 . Sick sinus syndrome 4 . Atrioventricular block first degree ( PR &gt; 0.24seconds ) , second third degree 5 . Other clinical significant arrhythmia 6 . Unstable and/or decompensated congestive heart failure 7 . Angina , acute myocardial infarction , percutaneous coronary intervention ( PCI ) , cardiac surgery 8 . Asthma moderate severe chronic obstructive pulmonary disease 9 . Type 1 diabetes mellitus 10 . Gout history 11 . Fasting serum glucose great 200 mg/dl ( 11.1 mmol/L ) type 2 diabetes mellitus need insulin therapy 12 . ALT &gt; 3ULN 13 . Cr &gt; 1.5mg/dl 14 . Pregnancy lactation . 15 . Alcohol drug abuse 16 . Known need concomitant antihypertensive therapy study besides study drug . 17 . Known suspected allergy investigational drug nonactive ingredient investigational drug , know allergy blocker , calcium antagonist , diuretic , angiotensin convert enzyme inhibitor contraindication . 18 . Suspected whitecoat hypertension base investigator 's judgement .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>